Mind the Gap
Some drug shortage prevention plans fail, while others succeed. Why? ISPE helps companies find the answer
Stephanie Sutton |
With the prevalence of drug shortages on the rise, the International Society for Pharmaceutical Engineering (ISPE) has stepped in to offer a helping hand by developing the Drug Shortages Prevention Plan (DSPP). The plan is based on a drug shortages survey performed in 2013, which pointed to several key factors to avoid shortages, including developing quality systems and strong management controls.
Often, drug shortages are attributed to an excessive number of recalls, unavailable materials or poor product quality, but ISPE asserts the issue usually runs deeper than that, and relates to a company’s overall system of capabilities, controls and culture. Regional economic issues also play a part, but the ISPE plan focuses on what companies can do internally to prevent drug shortages.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine